» Articles » PMID: 15939716

Communicating Prognosis in Cancer Care: a Systematic Review of the Literature

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2005 Jun 9
PMID 15939716
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Prognosis is an issue that most doctors and patients describe as difficult to discuss and the best way of presenting prognostic information to optimise patient understanding, psychological adjustment and decision-making is uncertain. A systematic review of the literature was conducted with the aim of clarifying the current available knowledge of patient preferences, clinician views and current practice regarding the communication of prognosis. Eleven primary research questions guided organisation of the review findings, which were: patient preferences for prognostic information and preferred style of communicating prognosis; disclosure of prognosis to family members; physicians' views on communication of prognosis; current practice of delivering prognostic information; patient understanding and awareness of prognostic information; cultural differences in preferences and understanding; impact of prognostic information on patient outcomes; and interventions to facilitate prognostic discussion. Predictors of patient preferences for and understanding of prognostic information were also summarised. Studies are summarised under the subcategories according to the participants' disease stage. It was found that the majority of the published research has been conducted in the early stage cancer setting providing mostly descriptive evidence, and there is little evidence of the best method of communicating prognosis or of the impact of prognostic information on patient outcomes.

Citing Articles

Risk-Prediction Models for Clinical Decision-Making in Sarcoma Care: An International Survey Among Soft-Tissue Sarcoma Clinicians.

Kruiswijk A, Vlug L, Acem I, Engelhardt E, Gronchi A, Callegaro D Ann Surg Oncol. 2025; 32(4):2958-2970.

PMID: 39893340 PMC: 11882627. DOI: 10.1245/s10434-024-16849-7.


Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial.

Piperno-Neumann S, De Koning L, Marchal T, Gastaud L, Waechter L, Fogliarini A Melanoma Manag. 2025; 11(1):2382080.

PMID: 39869447 PMC: 11318732. DOI: 10.1080/20450885.2024.2382080.


A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?.

Cherny N, Nortje N, Kelly R, Zimmermann C, Jordan K, Kreye G ESMO Open. 2025; 10(1):104099.

PMID: 39765188 PMC: 11758828. DOI: 10.1016/j.esmoop.2024.104099.


Facilitating patient-oncologist communication in advanced treatment-resistant cancer: development and feasibility testing of a question prompt list.

Rault A, Dolbeault S, Terrasson J, Bouleuc C, Cottu P, Piperno-Neumann S Pilot Feasibility Stud. 2024; 10(1):116.

PMID: 39198868 PMC: 11351337. DOI: 10.1186/s40814-024-01543-y.


MSFN: a multi-omics stacked fusion network for breast cancer survival prediction.

Zhang G, Ma C, Yan C, Luo H, Wang J, Liang W Front Genet. 2024; 15:1378809.

PMID: 39161422 PMC: 11331006. DOI: 10.3389/fgene.2024.1378809.